PUBLISHER: Allied Market Research | PRODUCT CODE: 1414703
PUBLISHER: Allied Market Research | PRODUCT CODE: 1414703
According to a new report published by Allied Market Research, titled, "Nebulizer Market," The nebulizer market was valued at $1.1 billion in 2022, and is estimated to reach $2.3 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032.
The nebulizer market growth is driven by increase in prevalence of respiratory diseases such as
1) asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulizers are commonly used to administer medication and manage these conditions. For instance, in 2022, according to National Library of Medicine, it was reported that, COPD affects 1 in 10 of the adult global population and is one of the three commonest causes of death worldwide. It is also a major cause of global inequalities in health and is more prevalent where such inequalities are more extreme.
Moreover, as the global population continues to age, there is a growing demand for respiratory care devices, including nebulizers, since older individuals are more susceptible to respiratory conditions. In addition, increase in levels of air pollution in many urban areas have led to a higher incidence of respiratory disorders and advances in nebulizer technology have improved their efficiency, ease of use, and portability, making them more appealing to both patients and healthcare providers.
In addition, a growing trend towards home healthcare and self-management of chronic illnesses has increased the use of nebulizers, as they can be used at home without the need for frequent hospital visits. Along with that Nebulizers are commonly used for children with respiratory issues, as they are effective and less intimidating than other delivery methods. The pediatric nebulizer market is a significant contributor to overall growth.
On the other hand, nebulizer devices, especially newer and more advanced models, can be expensive. This cost can be a barrier to access for some patients, particularly in regions with limited healthcare resources or for individuals with financial constraints. Thus, this factor is anticipated to restrain the growth of the market.
The nebulizer market is segmented into type, product, application, portability, end user, and region. Based on type the market is classified into jet nebulizer, ultrasonic nebulizer, and mesh nebulizer. Based on product, the market is segmented into equipment and accessories. Based on application the market is segmented into COPD, asthma and others. Based on potability, the market is bifurcated into tabletop and portable. Based on end user the market is divided into hospitals, clinics and homecare setting.
Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global nebulizer market are OMRON Healthcare, Inc, Koninklijke Philips N.V., DeVilbiss Healthcare LLC., GF Health Products, Inc., Trudell Medical International Inc., Allied Healthcare Products, Inc., Teleflex Incorporated, Vyaire Medical, Inc., PARI Respiratory Equipment Inc., and Rossmax International Ltd. Key players operating in the market have adopted product approval, product launch, acquisition, and agreement as their key strategies to expand their nebulizer market share.
Additional benefits you will get with this purchase are:
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)